Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes
- PMID: 28327975
- PMCID: PMC5834129
- DOI: 10.1093/annonc/mdx064
Statistical controversies in cancer research: using standardized effect size graphs to enhance interpretability of cancer-related clinical trials with patient-reported outcomes
Abstract
Patient reported outcomes (PROs) are becoming increasingly important in cancer studies, particularly with the emphasis on patient centered outcome research. However, multiple PROs, using different scales, with different directions of favorability are often used within a trial, making interpretation difficult. To enhance interpretability, we propose the use of a standardized effect size graph, which shows all PROs from a study on the same figure, on the same scale. Plotting standardized effects with their 95% confidence intervals (CIs) on a single graph clearly showing the null value conveys a comprehensive picture of trial results. We demonstrate how to create such a graph using data from a randomized controlled trial that measured 12 PROs at two time points. The 24 effect sizes and CIs are shown on one graph and clearly indicate that the intervention is effective and sustained.
Keywords: cancer; effect size; graphs; patient-reported outcomes; quality of life.
© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Figures
Comment in
-
Challenges of interpreting patient reported outcomes from clinical trials.Ann Transl Med. 2017 Oct;5(20):408. doi: 10.21037/atm.2017.07.23. Ann Transl Med. 2017. PMID: 29152508 Free PMC article. No abstract available.
References
-
- Patient Centered Outcomes Research Institute. PCORI Methodology Standards. Washington, DC: 2012; 1–16.
-
- Friedlander ML, King MT.. Patient-reported outcomes in ovarian cancer clinical trials. Ann Oncol 2013; 24: x64–x68. - PubMed
-
- Fairclough DL. Patient reported outcomes as endpoints in medical research. Stat Methods Med Res 2004; 13: 115–138. - PubMed
-
- Food, Administration D. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist 2009; 74: 65132–65133.
-
- Howell D, Molloy S, Wilkinson K. et al. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Ann Oncol 2015; 26(9): 1846–1858. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
